Warfarin dose related to apolipoprotein E (APOE) genotype (Q46542560)

23 December 2017

title

Warfarin dose related to apolipoprotein E (APOE) genotype (English)

1 reference

23 December 2017

1 reference

4

Mia Wadelius

1 reference

23 December 2017

Hugo Kohnke

1

1 reference

23 December 2017

Kristina Sörlin

series ordinal

2

1 reference

23 December 2017

Göran Granath

series ordinal

3

1 reference

23 December 2017

publication date

11 June 2005

1 reference

23 December 2017

European Journal of Clinical Pharmacology

published in

1 reference

23 December 2017

volume

61

1 reference

23 December 2017

issue

5-6

1 reference

23 December 2017

page(s)

381-388

1 reference

23 December 2017

Interactions of warfarin with drugs and food

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-005-0936-3

Receptor-mediated mechanisms of lipoprotein remnant catabolism

21 January 2018

1 reference

12 December 2020

Correlation of human cytochrome P4502C substrate specificities with primary structure: warfarin as a probe

1 reference

12 December 2020

Medicine: K is for koagulation.

1 reference

12 December 2020

Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention

1 reference

12 December 2020

Causative and susceptibility genes for Alzheimer's disease: a review.

1 reference

12 December 2020

The effect of simvastatin co-medication on warfarin anticoagulation response and dose requirements.

1 reference

12 December 2020

Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization

1 reference

12 December 2020

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

1 reference

12 December 2020

Determination of bleeding risk using genetic markers in patients taking phenprocoumon

1 reference

12 December 2020

Transport of vitamin K to bone in humans

1 reference

12 December 2020

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

1 reference

12 December 2020

Warfarin sensitivity related to CYP2C9, CYP3A5, ABCB1 (MDR1) and other factors.

1 reference

12 December 2020

Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9

1 reference

12 December 2020

Evidence of significant contribution from CYP3A5 to hepatic drug metabolism

1 reference

12 December 2020

CYP2C9*3 allelic variant and bleeding complications

1 reference

12 December 2020

Abnormal in vivo metabolism of apolipoprotein E4 in humans

1 reference

12 December 2020

Human cytochromes P4501A1 and P4501A2: R-warfarin metabolism as a probe

1 reference

12 December 2020

Genetic modulation of oral anticoagulation with warfarin

1 reference

12 December 2020

The physiology of vitamin K nutriture and vitamin K-dependent protein function in atherosclerosis.

1 reference

12 December 2020

Interindividual variability in sensitivity to warfarin--Nature or nurture?

1 reference

12 December 2020

CYP1A1 specificity of Verlukast epoxidation in mice, rats, rhesus monkeys, and humans

1 reference

12 December 2020

A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin.

1 reference

12 December 2020

Genetic association between sensitivity to warfarin and expression of CYP2C9*3

1 reference

12 December 2020

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range

1 reference

12 December 2020

Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy.

1 reference

12 December 2020

The APOE gene and differences in life expectancy in Europe

1 reference

12 December 2020

Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin.

1 reference

12 December 2020

Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations

1 reference

12 December 2020

TaqMan systems for genotyping of disease-related polymorphisms present in the gene encoding apolipoprotein E.

1 reference

12 December 2020

Pharmacogenetics of CYP2C9 and interindividual variability in anticoagulant response to warfarin

1 reference

12 December 2020

Vitamin K intake and sensitivity to warfarin in patients consuming regular diets

1 reference

12 December 2020

Allelic variants of human cytochrome P450 2C9: baculovirus-mediated expression, purification, structural characterization, substrate stereoselectivity, and prochiral selectivity of the wild-type and I359L mutant forms.

1 reference

12 December 2020

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

1 reference

12 December 2020

Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions

1 reference

12 December 2020

Human P450 metabolism of warfarin

1 reference

12 December 2020

Genetic mechanisms for hypersensitivity and resistance to the anticoagulant Warfarin

1 reference

12 December 2020

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance.

1 reference

12 December 2020

Phylloquinone transport and its influence on gamma-carboxyglutamate residues of osteocalcin in patients on maintenance hemodialysis.

1 reference

12 December 2020

Compound heterozygous mutations in the gamma-glutamyl carboxylase gene cause combined deficiency of all vitamin K-dependent blood coagulation factors

1 reference

12 December 2020

Pharmacogenetics of warfarin elimination and its clinical implications

1 reference

12 December 2020

10.1007/S00228-005-0936-3

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017